Hughes D C, Patel M V, Klinger H. "一种达格列净杂质34的合成方法" [P]. US Patent, US 9897702 B2, 2022-11-27.
发明人郭海燕,何建平,赵玉洁. "Method for the Synthesis of Dapagliflozin Impurity 34" [P]. 中国发明专利, 专利号 CN 117725268 A, 授权公告日 2022-12-02.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 达格列净杂质34 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2012, 1932, 5261-5290.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达格列净杂质34 as an Impurity". Anal. Methods, 2016, 297, (8), 937-964.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Dapagliflozin Impurity 34 Using HRMS and NMR". J. Sep. Sci., 2015, 775, 9712-9719.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 达格列净杂质34 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2025, 954, (10), 1436-1444.